Lung cancer immunotherapy: progress, pitfalls, and promises
A Lahiri, A Maji, PD Potdar, N Singh, P Parikh, B Bisht… - Molecular cancer, 2023 - Springer
Lung cancer is the primary cause of mortality in the United States and around the globe.
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Therapeutic options for lung cancer treatment include surgery, radiation therapy …
Epidemiology of lung cancer
Lung cancer is the leading cause of global cancer incidence and mortality, accounting for an
estimated 2 million diagnoses and 1.8 million deaths. Neoplasms of the lungs are the …
estimated 2 million diagnoses and 1.8 million deaths. Neoplasms of the lungs are the …
Cross-ancestry genome-wide meta-analysis of 61,047 cases and 947,237 controls identifies new susceptibility loci contributing to lung cancer
To identify new susceptibility loci to lung cancer among diverse populations, we performed
cross-ancestry genome-wide association studies in European, East Asian and African …
cross-ancestry genome-wide association studies in European, East Asian and African …
Surgical treatment of lung cancer
H Hoy, T Lynch, M Beck - Critical Care Nursing Clinics, 2019 - ccnursing.theclinics.com
Lung cancer is the leading cause of cancer-related death and the second most diagnosed
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …
cancer for both men and women in the United States 1, 2 More than 25, 000 surgeries for …
Liquid biopsy for lung cancer: up-to-date and perspectives for screening programs
GMS Casagrande, MO Silva, RM Reis… - International Journal of …, 2023 - mdpi.com
Lung cancer is the deadliest cancer worldwide. Tissue biopsy is currently employed for the
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
diagnosis and molecular stratification of lung cancer. Liquid biopsy is a minimally invasive …
PVT1 lncRNA in lung cancer: A key player in tumorigenesis and therapeutic opportunities
The lncRNA PVT1 has emerged as a pivotal component in the intricate landscape of cancer
pathogenesis, particularly in lung cancer. PVT1, situated in the 8q24 chromosomal region …
pathogenesis, particularly in lung cancer. PVT1, situated in the 8q24 chromosomal region …
Emerging landscape of circular RNAs in lung cancer
Lung cancer, the leading cause of cancer deaths worldwide, is characterized with malignant
cell growth. Advances in next-generation sequencing has helped us further understand RNA …
cell growth. Advances in next-generation sequencing has helped us further understand RNA …
Alternative splicing in lung cancer
Lung cancer has the highest mortality rate of all cancers worldwide. Lung cancer is a very
heterogeneous disease that is often diagnosed at later stages which have a poor prognosis …
heterogeneous disease that is often diagnosed at later stages which have a poor prognosis …
Towards machine learning-aided lung cancer clinical routines: Approaches and open challenges
Advancements in the development of computer-aided decision (CAD) systems for clinical
routines provide unquestionable benefits in connecting human medical expertise with …
routines provide unquestionable benefits in connecting human medical expertise with …
CircRNA fibroblast growth factor receptor 3 promotes tumor progression in non‐small cell lung cancer by regulating Galectin‐1‐AKT/ERK1/2 signaling
BQ Qiu, PF Zhang, D **ong, JJ Xu… - Journal of cellular …, 2019 - Wiley Online Library
The dysregulation of circular RNA (circRNA) expression is involved in the progression of
several cancers, including non‐small cell lung cancer (NSCLC). However, the role and …
several cancers, including non‐small cell lung cancer (NSCLC). However, the role and …